Published Online: Friday, September 1, 2006

The American Society of Consultant Pharmacists (ASCP) recently addressed medication therapy management services (MTMS) in long-term care. MTMS programs are expected to (1) optimize therapeutic outcomes through improved medication use; (2) reduce the risk of adverse events, including adverse drug interactions; (3) be conducted by a pharmacist or other qualified health care provider; and (4) differentiate between services in ambulatory and institutional settings.

In its policy statement, ASCP highlighted the following points:

  • ASCP advocates that Part D sponsors provide flexibility in the MTMS offered to patients of long-term care facilities and that these services mirror the unique differences in these residents and settings
  • The MTMS program should mainly focus on optimizing therapeutic outcomes and reducing adverse drug events for the beneficiary, and secondarily focus on reductions of drug costs when necessary
  • Pharmacists who provide MTMS to long-term care facility residents should have expertise in geriatric drug therapy
  • MTMS recommendations received by the administrator, prescriber, pharmacy provider, or caregiver/resident are best reconciled by the facility's consultant pharmacist

Latest Articles
Having trouble getting your hands on FluMist?
Novartis is paying $390 million to settle charges that it paid kickbacks to pharmacies to encourage drug sales.
Anxiety sensitivity has been linked to more debilitating asthma symptoms and greater functional limitations.
Nasal corticosteroid sprays do not seem to be viable treatments for the common cold.
Latest Issues